LCMS analysis was performed using a Waters Symmetry ® C18 5µm column (3.9 x 150 mm) or a Waters Sunfire ® C8 5µm column (4.6 x 150 mm), using solvent systems A (20% isopropanol and 0.1% TFA in H 2 O) and B (20% isopropanol and 0.1% TFA in acetonitrile), at a flowrate of 1 mL/min.
Before running the reactor it was rinsed with a copious amount of DMF at the reaction temperature. Next the system was equilibrated by rinsing the reactor with 250 µL pre-quench reaction volume at the appropriate speed. The reactor was run until the syringes were empty.
The reaction mixture was collected, diluted with CH 2 Cl 2 , washed with aqueous KH 2 PO 4 (1 M) and aqueous K 2 HPO 4 (1 M), dried (NaSO 4 ) and concentrated. To purify the crude fluorous products the mixture was taken up in DMF and loaded onto a fluorous silica column (Fluorochrom silicagel), which was first eluted with MeOH/H 2 O (80/20) followed by MeOH and MeOH/CH 2 Cl 2 (1/1). The MeOH and MeOH/DCM fractions were collected and concentrated to provide the pure target compound. The non-fluorous products were purified using silica gel column chromatography.
General procedure for the synthesis of the acid fluorides from the parent amino acids:
The appropriate protected amino acid (1 equiv.) in CH 2 Cl 2 (8 mL/1 mmol) was treated with pyridine (1 equiv.) and cyanuric fluoride (0.5 equiv.). After stirring for 3 h at r.t. the mixture was diluted with CH 2 Cl 2 and washed twice with a small amount of ice water. The organic phase was dried (Na 2 SO 4 ) and the solvent was removed under reduced pressure. The so obtained acid fluoride was used for the reaction without further purification. (CH 2 ), 120.0, 125.0, 127.1, 127.1, 127.7, 128.9, 129.1 (7 x CH), 136.6, 141.3, 143.7, 155.5 (4 x C). Carbonyl-C-atom could not be detected due to low intensity.
BocHN F O Ph
Boc-β 3 -homophenylalanine fluoride (purity > 90%) BocHN 
General procedure for the deprotection of the Boc-protected peptides:
The Boc-protected amino acid was dissolved in TFA (5mL/1 mmol) at 0°C. Stirring for 0.5 h at 0°C and for 1.5 h at r.t., concentration under reduced pressure, coevaporation with toluene (2 x) and drying under high vacuum yielded the crude TFA salt which was used without further purification.
General procedure for hydrogenation of the protected tetrapeptides:
The tetrapeptide (1 mg/mL) was dissolved in EtOAc/tBuOH/H 2 O (2:2:1) and treated with 1.5 weight equivalents Pd/C (10% Pd). H 2 -gas was bubbled through the solution for 1 minute after which the mixture was stirred under a hydrogen atmosphere for 2.5 hours. The Pd/C was filtered off and the solvents were evaporated. Tripeptide 14b was deprotected as described above. The water/MeOH fraction was collected, evaporated, taken up in water and lyophilized.
Fluffy white solid. LCMS analysis (C8-column, 5% B in A: 2 min.; linear gradient to 50% in 9 min.), t R (major diastereomer): 7.7 min, t R (minor diastereomer): 6.1 min.; major:minor diastereomer = 11:1. Purity >96%. General procedure for peptide coupling using HATU.
The appropriate N-deprotected amino acid (1 equiv.) was dissolved in DMF (20 mL/1 mmol) and cooled in an ice-bath. To the mixture was successively added NMM (4 equiv.) and the N- Esterification of the Fmoc-protected amino acid with Wang resin was performed according to [1] , by the MSNT/MeIm method. The resin was placed into a dried manual SPS reactor, swelled in CH 2 Cl 2 (20 mL/g resin) for 1 h and washed with CH 2 Cl 2 . In a separate dry roundbottomed flask equipped with magnetic stirrer, the Fmoc-protected amino acid (5 equiv.) was dissolved in dry CH 2 Cl 2 (5 mL/mmol), then MeIm (3.75 equiv.) and MSNT (5 equiv.) were added under Ar. Stirring was continued until the MSNT was dissolved. Thereafter, the solution was transferred using a syringe to the reaction vessel containing the resin and mixed by N 2 bubbling for 2 h. Subsequently, the resin was filtered, washed with DMF (5 mL, 5 × 1 min) 1 min) and CH 2 c 2 , [mM] ) of the benzofulvene-piperidine adduct in soln. were determined using a calibration curve [1] . The loading (Subst.) was then calculated according to equation (1) The yield for the attachment to the resin (loading yield) was determined by equation (2):
General procedure for capping.
Unreacted OH groups were capped by treating the peptide-resin with 50 mg DMAP in 5 mL DMF and 1 mL Ac 2 O for 1 h under N 2 -bubbling. The resin was then washed with DMF (5 mL, 5 × 1 min).
General procedure for Fmoc-deprotection.
The Fmoc-group was removed by treating the resin with 20% piperidine in DMF (4 mL, 4 × 10 min) under Ar bubbling. After filtration, the resin was washed with DMF (5 mL, 4 × 1 min).
General procedure for coupling of the  amino acids on Wang resin.
The Fmoc-deprotection was carried out according to general procedure for Fmocdeprotection. Solid phase synthesis was continued by sequential incorporation of Fmocprotected amino acids. For each coupling step, the resin was treated with a soln. of the Fmocprotected amino acid (3 equiv.), HATU (2.8 equiv.) both in the minimal amount of DMF and Hünig base (6 equiv.) in DMF (20 mL/g resin) for 60 min. Monitoring of the coupling reaction was performed with the TNBS test [2] . In the case of a positive TNBS test (indicating incomplete coupling), the suspension was allowed to react further for 0.5 h. The resin was then filtered and washed with DMF (20 mL/g resin, 5 × 1 min) prior to the following deprotection step. After the last coupling, the Fmoc group of the last amino acid was removed as previously described (General procedure for Fmoc-deprotection), and the resin was washed with DMF (20 mL/g resin, 5 × 1 min) and with CH 2 Cl 2 (20 mL/g resin, 5 × 1 min),
and dried under h. v. overnight.
General procedure for cleavage from the Wang resin and final deprotection.
The cleavage from the resin and the peptide deprotection were performed according to [3] .
The dry peptide-resin was suspended in a soln. of TFA/H 2 O/TIS 95:2.5:2.5 (10 mL) for 2 h. 
